Guilherme Agreli

  • Citations Per Year
Learn More
INTRODUCTION The conventional aortic valve replacement is the treatment of choice for symptomatic severe aortic stenosis. Transcatheter technique is a viable alternative with promising results for inoperable patients. Sutureless bioprostheses have shown benefits in high-risk patients, such as reduction of aortic clamping and cardiopulmonary bypass,(More)
I have read the “Innovation and Excellence: Changing to prevail the Brazilian Cardiovascular Surgery” editorial written by Professor Walter J. Gomes [1], and found it to be at the same time lucid and honest, as the story is told by its protagonist. I want to congratulate the author on his tenure at the Brazilian Society of Cardiovascular Surgery (SBCCV), on(More)
OBJECTIVE Heart failure is currently one of the most common hospitalization causes. Several chronic circulatory assist devices have been tested and are highly complex. The objective is the description of a pulsatile endoprosthesis capable of applying a chronic pulse within the descending aorta, similar to that produced by intra-aortic balloon. METHODS(More)
OBJECTIVE The aortic valve replacement is a routine procedure with acceptable risk, but in some cases, such a risk can justify contraindication. The minimally invasive transcatheter aortic valve implantation has been viable, with lower morbidity and mortality. The aim of this study was to develop a national catheter-mounted aortic bioprosthesis for the(More)
Transcatheter aortic valve implantation (TAVI) is a relatively new medical intervention. Research on dedicated TAVI devices is an exciting and dynamic field to be explored by professionals involved in technological innovation. The authors describe in this article the first engineering concept and part of the US Patent of a new valve prosthesis. Divided into(More)
  • 1